In cancerous cells, highly expressed oncogenic signaling pathway components, such as PI3K/AKT, JAK/STAT, and oncogenic fusion proteins, have been reported to be cancer-relevant client proteins of HSP9015–18. This evidence concerns the gene AKT1 and cancer.